 Effects beta-adrenergic stimulation dobutamine isovolumic relaxation normal human ventricle BACKGROUND hypothesis beta-adrenergic receptor-stimulated acceleration left ventricular LV isovolumic relaxation positive lusitropic response patients severe congestive heart failure CHF patients LV dysfunction CHF METHODS RESULTS beta-adrenergic agonist dobutamine intracoronary route subjects normal group CHF patients intravenous route second group subjects normal group CHF patients positive inotropic response intravenous dobutamine patients CHF LV isovolumic relaxation rate methods Weiss TL Mirsky nonlinear regression technique TNL LV isovolumic relaxation methods CHF patients normal subjects Intracoronary intravenous infusions dobutamine significant acceleration LV isovolumic relaxation normal subjects patients CHF magnitude dobutamine-stimulated acceleration isovolumic relaxation patients CHF comparable normal subjects CONCLUSIONS data beta-adrenergic receptor stimulation significant acceleration LV isovolumic relaxation normal subjects patients severe CHF Coronary hypothesis lusitropic response beta-adrenergic stimulation patients severe CHF substantial attenuation beta-adrenergic positive inotropic response findings important implications physiology pharmacology LV relaxation humans